Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19

Karsten Buschard*

*Corresponding author af dette arbejde

Abstract

Fenofibrate, which is a PPAR-alfpha agonist, increases the level of sulfatide. In this letter we hypothesize on the background of various findings that this is beneficial against COVID-19. Fenofibrate has been used for decades against hypercholesterolemia and has no serious side effects. Therefore, a trial giving fenofibrate to patients with corona virus infection is recommended.

OriginalsprogEngelsk
TidsskriftMedical Hypotheses
Vol/bind143
Sider (fra-til)110127
ISSN0306-9877
DOI
StatusUdgivet - okt. 2020

Fingeraftryk

Dyk ned i forskningsemnerne om 'Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19'. Sammen danner de et unikt fingeraftryk.

Citationsformater